Advances for achieving a pathological complete response for rectal cancer after neoadjuvant therapy

Neoadjuvant therapy has become the standard of care for locally advanced mid-low rectal cancer. Pathological complete response (pCR) can be achieved in 12%–38% of patients. Patients with pCR have the most favorable long-term outcomes. Intensifying neoadjuvant therapy and extending the interval betwe...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Chronic Dis Transl Med
Asıl Yazarlar: Cui, Jian, Fang, Hui, Zhang, Lin, Wu, Yun-Long, Zhang, Hai-Zeng
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: KeAi Publishing 2016
Konular:
Perspective
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5643745/
https://ncbi.nlm.nih.gov/pubmed/29063019
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cdtm.2016.06.001
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller